Krystal Biotech's GAAP loss for 6M 2021 was $32.174 million, up 2.6x% from $12.174 million in the prior year
Krystal Biotech's GAAP loss for 6M 2021 was $32.174 million, up 2.6x% from $12.174 million in the prior year
Financial results
Krystal Biotech's GAAP loss for 6M 2021 was $32.174 million, up 2.6x% from $12.174 million in the prior year Source: 
ir.krystalbio.com
ir.krystalbio.com News feed
English (US) 